EUVIMEDEUVIMED entdecken
Fallbericht

Using Intralesional Adalimumab for Chronic Refractory Cutaneous Granulomatous Inflammation

Houriah Y Nukaly, Siddharth Srikakolapu, Dirk M Elston

Cutis · 01.06.2026 · 6 (117)

DOI: 10.12788/cutis.1406 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cutis, erschienen am 01.06.2026. Verfasst von Houriah Y Nukaly und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Nukaly is from the Division of Experimental Medicine, McGill University Health Centre, Montréal, Québec, Canada. Drs. Srikakolapu and Elston are …. Hauptthemen laut MEDLINE: Adalimumab, Anti-Inflammatory Agents, Granuloma, Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdalimumabAnti-Inflammatory AgentsGranulomaSkin DiseasesHumansInjections, IntralesionalTumor Necrosis Factor-alphaChronic Disease

Substanzen

AdalimumabAnti-Inflammatory AgentsTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Dr. Nukaly is from the Division of Experimental Medicine, McGill University Health Centre, Montréal, Québec, Canada. Drs. Srikakolapu and Elston are from the Department of Dermatology and Dermatologic Surgery, Medical U…

Zitieren

APA

Nukaly, H. Y., Srikakolapu, S., & Elston, D. M. (2026). Using Intralesional Adalimumab for Chronic Refractory Cutaneous Granulomatous Inflammation. Cutis, 6(117). https://doi.org/10.12788/cutis.1406

Vancouver

Nukaly HY, Srikakolapu S, Elston DM. Using Intralesional Adalimumab for Chronic Refractory Cutaneous Granulomatous Inflammation. Cutis. 2026;6(117). doi:10.12788/cutis.1406

BibTeX
@article{Nukaly2026,
  author = {Nukaly, Houriah Y and Srikakolapu, Siddharth and Elston, Dirk M},
  title = {Using Intralesional Adalimumab for Chronic Refractory Cutaneous Granulomatous Inflammation},
  journal = {Cutis},
  year = {2026},
  volume = {6},
  number = {117},
  doi = {10.12788/cutis.1406}
}
Kostenlos starten →